(Total Views: 116)
Posted On: 09/15/2025 11:07:08 AM
Post# of 108981

$CVM CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
https://finance.yahoo.com/news/cel-sci-multik...00923.html

